Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 153 entries
View as:

Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study

Phase: N/A Priority: Normal
NCT ID: NCT05554003 Org: User:
Start: 01/14/22 End: 12/31/24 Due: 12/31/25

Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06566404 Org: User:
Start: 10/30/24 End: 01/01/28 Due: 01/01/29

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00301548 Org: User:
Start: 02/29/00 End: 06/30/05 Due: 06/30/06

Bowel Cleansing for Colonoscopy: Comparison Between a Same Day Low-Volume Preparation and a Conventional 4L Split One

Phase: N/A Priority: Normal
NCT ID: NCT01685853 Org: User:
Start: 04/30/11 End: 03/31/12 Due: 03/31/13

Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03971045 Org: User:
Start: 05/20/20 End: 03/01/25 Due: 03/01/26

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone

Phase: N/A Priority: Normal
NCT ID: NCT06321666 Org: User:
Start: 09/12/19 End: 12/31/24 Due: 12/31/25

Multimedia-assisted Informed Consent Procedure for Patients Undergoing Mastectomy and Implant-based Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT06541223 Org: User:
Start: 01/02/24 End: 06/25/24 Due: 06/25/25

IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4

Phase: N/A Priority: Normal
NCT ID: NCT06703567 Org: User:
Start: 09/06/24 End: 12/31/25 Due: 12/31/26

Fenretinide in Healthy Young Women at Genetic and Familial Risk

Phase: N/A Priority: Normal
NCT ID: NCT01479192 Org: User:
Start: 12/31/09 End: 12/31/15 Due: 12/31/16

PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients

Phase: N/A Priority: Normal
NCT ID: NCT06541301 Org: User:
Start: 12/31/24 End: 02/28/26 Due: 02/28/27

Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00970983 Org: User:
Start: 03/31/98 End: 04/30/10 Due: 04/30/11

Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region

Phase: N/A Priority: Normal
NCT ID: NCT06335238 Org: User:
Start: 02/22/18 End: 12/31/24 Due: 12/31/25

What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT06326242 Org: User:
Start: 03/27/23 End: 12/31/24 Due: 12/31/25

Comparison of Mechanical Bowel Preparation Versus Enema for Candidates to Colorectal Resection for Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00940030 Org: User:
Start: 10/31/07 End: 12/31/17 Due: 12/31/18

Epigenomic and Machine Learning Models to Predict Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06334458 Org: User:
Start: 02/03/23 End: 12/31/24 Due: 12/31/25

Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

Phase: N/A Priority: Normal
NCT ID: NCT04434417 Org: User:
Start: 04/15/20 End: 12/31/21 Due: 12/31/22

Contrast-Enhanced Spectral Mammography (CESM)

Phase: N/A Priority: Normal
NCT ID: NCT06311695 Org: User:
Start: 11/16/20 End: 12/31/25 Due: 12/31/26

Value-Based Medicine (VBM) for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06703866 Org: User:
Start: 01/27/21 End: 12/31/24 Due: 12/31/25

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01264874 Org: User:
Start: 05/31/10 End: 07/31/17 Due: 07/31/18

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002747 Org: User:
Start: 09/30/92 End: - Due: -

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06726889 Org: User:
Start: 01/25/24 End: 04/30/25 Due: 04/30/26

Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration

Phase: N/A Priority: Normal
NCT ID: NCT06762379 Org: User:
Start: 12/20/24 End: 12/31/30 Due: 12/31/31

Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District

Phase: N/A Priority: Normal
NCT ID: NCT03001570 Org: User:
Start: 01/31/14 End: 12/31/23 Due: 12/31/24

Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04679454 Org: User:
Start: 07/31/21 End: 03/31/29 Due: 03/31/30

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01375023 Org: User:
Start: 06/30/09 End: 12/31/13 Due: 12/31/14